NEW YORK, April 26, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Epidemiology: Multiple Sclerosis
http://www.reportlinker.com/p0484930/Epidemiology-Multiple-Sclerosis.html
The prevalence of multiple sclerosis (MS) has increased over the last half century in many countries. The current prevalence of MS in the seven major markets (the US, Japan, France, Germany, Italy, Spain, and the UK) is estimated at approximately 80 diagnosed cases per 100,000 people. The increase in MS is likely the result of improved survival and earlier detection, among other factors.Gain insight to market potential, including a robust 10-year epidemiology forecast of multiple sclerosis prevalent cases.Understand the key epidemiologic risk factors associated with multiple sclerosis.During 2010, Datamonitor estimates that 575,900 prevalent cases of multiple sclerosis (MS) existed in the seven major markets (the US, Japan, France, Germany, Italy, Spain, and the UK). Between 2010 and 2020, Datamonitor forecasts annual MS prevalent cases in the seven major markets to increase by 1.5%, resulting in 584,500 prevalent cases in 2020.In the five major EU markets (France, Germany, Italy, Spain, and the UK), Datamonitor estimates that 315,600 prevalent MS cases existed in 2010. This constitutes 55% of all prevalent cases estimated for the seven major markets. Between 2010 and 2020, the number of ASD cases will decrease by 2.0% to 309,200.During 2010 in the seven major markets, Datamonitor estimates that the majority (63%) of MS prevalent cases were of the relapse/remitting form. In absolute terms, 363,300 prevalent MS cases were relapse/remitting MS and 212,600 cases were all other MS subtypes in the seven major markets.What are the most robust sources for multiple sclerosis prevalence data?How will the patient population change over the next decade in the US, Japan, and five major EU markets (France, Germany, Italy, Spain, and the UK)?What are the major influencing factors for multiple sclerosis that drive the trend in prevalent cases and how are they changing?
Executive Summary
Disease burden overview
Forecast results (2010–20)
OVERVIEW
Catalyst
Summary
DISEASE DEFINITION AND DIAGNOSIS CRITERIA
Diagnosing multiple sclerosis
Classifying multiple sclerosis
GLOBAL VARIATION AND HISTORICAL TRENDS
Diagnosed multiple sclerosis prevalence has increased over time and varies across the seven major markets
Overview
Females are more predisposed to multiple sclerosis than males
Multiple sclerosis prevalence trends and latitudinal effects
CO-MORBIDITIES
Co-morbidities are not covered due to lack of available literature
RISK FACTORS
Genetic factors
Genes and polymorphisms
Monozygotic twin studies
Environmental factors
UV light exposure and vitamin D
Infectious diseases
Demographic factors
Race and ethnicity
Sex
EPIDEMIOLOGIC FORECASTING OF MULTIPLE SCLEROSIS
Overview
Population denominators
Sub-populations
Age
Sex
Subtype
Diagnosis certainty
Presenting symptoms
Age-standardized prevalence
US
Sources used
Methods
Sources not used
Japan
Sources used
Methods
Sources not used
France
Sources used
Methods
Sources not used
Germany
Sources used
Methods
Sources not used
Italy
Sources used
Methods
Sources not used
Spain
Sources used
Methods
Sources not used
UK
Sources used
Methods
Sources not used
EPIDEMIOLOGIC RESULTS
Estimated prevalent cases of autism spectrum disorders and future trends
Segmentation of prevalent cases
DISCUSSION
Strength of Datamonitor's epidemiologic projections
Conclusions
BIBLIOGRAPHY
Journal papers
Websites
Datamonitor reports
APPENDIX
Module methodology
To order this report:
: Epidemiology: Multiple Sclerosis
Check our Company Profile, SWOT and Revenue Analysis!
CONTACT
Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626
SOURCE Reportlinker